STOCKSWhat Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016By Adam FeuersteinDec 22, 2016 11:20 AM EST
MARKETSInsider Trading Alert - HEB, EPAY And STOR Traded By InsidersBy TheStreet WireMar 15, 2016 10:15 AM EDT
MARKETSInsider Trading Alert - SKT, HEB And NURO Traded By InsidersBy TheStreet WireAug 21, 2015 10:15 AM EDT
MARKETSInsider Trading Alert - NDAQ, FEYE And HEB Traded By InsidersBy James Giaquinto Apr 29, 2015 11:47 AM EDT
MARKETSInsider Trading Alert - KCG, HEB And OXM Traded By InsidersBy Brian HamiltonApr 23, 2015 11:00 AM EDT
MARKETSInsider Trading Alert - HEB, MS And IMPV Traded By InsidersBy Brian HamiltonApr 22, 2015 10:15 AM EDT
MARKETSInsider Trading Alert - FTD, HEB And AWH Traded By InsidersBy James Giaquinto Apr 20, 2015 11:00 AM EDT
STOCKSHemispherx Uses Ebola Tragedy to Raise Cash, Pay Executive BonusesBy Adam FeuersteinMar 10, 2015 11:10 AM EDT
OPINIONRegulators Want Drug Companies to Be Honest About FDABy Adam FeuersteinMar 4, 2015 1:08 PM EST
STOCKSBiotech Stock Mailbag: Hep C stocks, Bluebird, Advaxis, HemispherxBy Adam FeuersteinFeb 6, 2015 6:05 AM EST
STOCKSU.S. Army Medical Researchers to Hemispherx: We're Really Not That Into YouBy Adam FeuersteinFeb 4, 2015 12:59 PM EST
STOCKSBiotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, HemispherxBy Adam FeuersteinOct 31, 2014 6:40 AM EDT
STOCKSEbola Outbreak Puts the Spotlight on 10 Biotech CompaniesBy Laurie KulikowskiOct 8, 2014 12:32 PM EDT
STOCKSWhy You Should Stay Away From the Ebola Frenzy in Biotech StocksBy Adam FeuersteinOct 1, 2014 10:08 AM EDT
STOCKSTrade Ebola Stocks? Sure, But Don't Bet on Big Business OpportunityBy David SobekSep 10, 2014 9:36 AM EDT
INVESTINGSarepta Should Shut Up About Ebola, Focus on Job No. 1By Adam FeuersteinAug 6, 2014 12:07 PM EDT
STOCKSAn Outrageous, Shameless Act by Hemispherx's Board of DirectorsBy Adam FeuersteinMay 1, 2013 12:03 PM EDT
STOCKSSarepta Bear Speaks: Eteplirsen Accelerated Approval Will Be DeniedBy Aafia ChaudhryFeb 11, 2013 7:00 AM EST
